Fish Oil And Vitamin D Pills No Guard Against Cancer Or Serious Heart Trouble
And new study finds no reason to get routine vitamin D tests, researchers say.
The independent source for health policy research, polling, and news.
2,101 - 2,120 of 3,938 Results
And new study finds no reason to get routine vitamin D tests, researchers say.
The dialysis industry raised nearly $111 million in a successful bid to defeat the measure, which also was opposed by hospitals and doctors. The union that sponsored the measure collected about one-sixth that amount.
KHN's news analysis on "Medicare-for-all" sparks a broader conversation.
One of the most popular electronic health records software systems used by hospitals, Epic Systems, can delete records or require cumbersome workarounds when clocks are set back for an hour, prompting many hospitals to opt for paper records for part of the night shift.
A number of health issues â from preexisting conditions to Medicaid expansion to changes to Medicare â could be at stake when voters head to the polls Tuesday.
Critics worry the marketing of Vascepa, a purified fish oil product, could prove a fish story.
The money was paid on behalf of more than 400,000 people who may have been ineligible for the public program, a state audit found. One had been dead for four years before payments stopped.
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often wonât cover the skyrocketing cost.
Although dialysis provider DaVita Inc. has taken major financial hits this year, including a $383.5 million jury award in response to wrongful death lawsuits, it still rakes in profits. The company faces its biggest threat next month, when California voters weigh in on a ballot initiative that could force it to leave the state.
A California college professor never imagined that trying to figure out what was causing her rash could add up to such a huge bill.
Union-backed initiatives in Palo Alto and Livermore, Calif., aim to cap charges by hospitals and doctors, seeking to build on national furor over rising medical bills. The measures arise in health care markets that are among the most expensive in the nation.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.
Federal law guarantees that people have the right to see and obtain a copy of their medical records. But, hospitals, doctors, pharmacies and insurance companies often erect obstacles.
As rates of sexually transmitted diseases surge, public health officials want physicians to step up screening and treatment of patients.
Candidates are charging toward midterm elections on a platform of single-payer and universal coverage rhetoric. Yet âMedicare-for-allâ and single-payer mean different things to different people.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
Insurance companies profit from government contracts but are subject to little oversight of how they spend the money or care for patients. The expansion of Medicaid under the Affordable Care Act has only exacerbated the problem.
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicareâs annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.
Š 2026 KFF